These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
609 related items for PubMed ID: 16740691
1. Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression. Toyo-oka K, Bowen TJ, Hirotsune S, Li Z, Jain S, Ota S, Escoubet-Lozach L, Garcia-Bassets I, Lozach J, Rosenfeld MG, Glass CK, Eisenman R, Ren B, Hurlin P, Wynshaw-Boris A. Cancer Res; 2006 Jun 01; 66(11):5565-73. PubMed ID: 16740691 [Abstract] [Full Text] [Related]
2. Loss of the Max-interacting protein Mnt in mice results in decreased viability, defective embryonic growth and craniofacial defects: relevance to Miller-Dieker syndrome. Toyo-oka K, Hirotsune S, Gambello MJ, Zhou ZQ, Olson L, Rosenfeld MG, Eisenman R, Hurlin P, Wynshaw-Boris A. Hum Mol Genet; 2004 May 15; 13(10):1057-67. PubMed ID: 15028671 [Abstract] [Full Text] [Related]
3. Of Myc and Mnt. Hooker CW, Hurlin PJ. J Cell Sci; 2006 Jan 15; 119(Pt 2):208-16. PubMed ID: 16410546 [Abstract] [Full Text] [Related]
4. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability. McCormack SJ, Weaver Z, Deming S, Natarajan G, Torri J, Johnson MD, Liyanage M, Ried T, Dickson RB. Oncogene; 1998 May 28; 16(21):2755-66. PubMed ID: 9652742 [Abstract] [Full Text] [Related]
5. Mnt takes control as key regulator of the myc/max/mxd network. Wahlström T, Henriksson M. Adv Cancer Res; 2007 May 28; 97():61-80. PubMed ID: 17419941 [Abstract] [Full Text] [Related]
6. Mnt transcriptional repressor is functionally regulated during cell cycle progression. Popov N, Wahlström T, Hurlin PJ, Henriksson M. Oncogene; 2005 Dec 15; 24(56):8326-37. PubMed ID: 16103876 [Abstract] [Full Text] [Related]
7. Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice. Jäger R, Herzer U, Schenkel J, Weiher H. Oncogene; 1997 Oct 09; 15(15):1787-95. PubMed ID: 9362445 [Abstract] [Full Text] [Related]
8. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis. Amundadottir LT, Johnson MD, Merlino G, Smith GH, Dickson RB. Cell Growth Differ; 1995 Jun 09; 6(6):737-48. PubMed ID: 7669729 [Abstract] [Full Text] [Related]
9. TGF beta regulation of cell proliferation. Moses HL, Arteaga CL, Alexandrow MG, Dagnino L, Kawabata M, Pierce DF, Serra R. Princess Takamatsu Symp; 1994 Jun 09; 24():250-63. PubMed ID: 8983080 [Abstract] [Full Text] [Related]
10. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis. Liao DJ, Natarajan G, Deming SL, Jamerson MH, Johnson M, Chepko G, Dickson RB. Oncogene; 2000 Mar 02; 19(10):1307-17. PubMed ID: 10713672 [Abstract] [Full Text] [Related]
11. Inflammatory disease and lymphomagenesis caused by deletion of the Myc antagonist Mnt in T cells. Dezfouli S, Bakke A, Huang J, Wynshaw-Boris A, Hurlin PJ. Mol Cell Biol; 2006 Mar 02; 26(6):2080-92. PubMed ID: 16507988 [Abstract] [Full Text] [Related]
12. Developmental stage determines the effects of MYC in the mammary epithelium. Blakely CM, Sintasath L, D'Cruz CM, Hahn KT, Dugan KD, Belka GK, Chodosh LA. Development; 2005 Mar 02; 132(5):1147-60. PubMed ID: 15689376 [Abstract] [Full Text] [Related]
13. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis. Gallahan D, Jhappan C, Robinson G, Hennighausen L, Sharp R, Kordon E, Callahan R, Merlino G, Smith GH. Cancer Res; 1996 Apr 15; 56(8):1775-85. PubMed ID: 8620493 [Abstract] [Full Text] [Related]
14. Chromatin dynamics at the hTERT promoter during transcriptional activation and repression by c-Myc and Mnt in Xenopus leavis oocytes. Wahlström T, Belikov S, Arsenian Henriksson M. Exp Cell Res; 2013 Dec 10; 319(20):3160-9. PubMed ID: 23860446 [Abstract] [Full Text] [Related]
15. Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis. Hurlin PJ, Zhou ZQ, Toyo-oka K, Ota S, Walker WL, Hirotsune S, Wynshaw-Boris A. EMBO J; 2003 Sep 15; 22(18):4584-96. PubMed ID: 12970171 [Abstract] [Full Text] [Related]
16. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cabodi S, Tinnirello A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P. Cancer Res; 2006 May 01; 66(9):4672-80. PubMed ID: 16651418 [Abstract] [Full Text] [Related]
17. Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis. Hurlin PJ, Foley KP, Ayer DE, Eisenman RN, Hanahan D, Arbeit JM. Oncogene; 1995 Dec 21; 11(12):2487-501. PubMed ID: 8545105 [Abstract] [Full Text] [Related]
18. Overexpression of aromatase leads to hyperplasia and changes in the expression of genes involved in apoptosis, cell cycle, growth, and tumor suppressor functions in the mammary glands of transgenic mice. Kirma N, Gill K, Mandava U, Tekmal RR. Cancer Res; 2001 Mar 01; 61(5):1910-8. PubMed ID: 11280746 [Abstract] [Full Text] [Related]
19. Kinetics of myc-max-mad gene expression during hepatocyte proliferation in vivo: Differential regulation of mad family and stress-mediated induction of c-myc. Mauleon I, Lombard MN, Muñoz-Alonso MJ, Cañelles M, Leon J. Mol Carcinog; 2004 Feb 01; 39(2):85-90. PubMed ID: 14750213 [Abstract] [Full Text] [Related]
20. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice. Kitsberg DI, Leder P. Oncogene; 1996 Dec 19; 13(12):2507-15. PubMed ID: 9000125 [Abstract] [Full Text] [Related] Page: [Next] [New Search]